According to the recent research report titled ‘Europe Apheresis Equipment Market Size By Product, Application, Procedure, Technology, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Europe apheresis equipment market is projected to grow substantially during the forecast period to amass USD 1.2 billion by 2026.
 

Growing pervasiveness of blood related disorders, technological advancements, presence of favorable reimbursement policies, and rising elderly population prone to chronic diseases are the key factors driving the growth of Europe apheresis equipment market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683091/
 

As per European Commission, 19.2% of total EU-28 population are aged 65 years and above. High susceptibility of geriatric population  for several chronic diseases such as arthritis, hepatitis, lung disorder, anemia, renal disorders, cardiovascular diseases, and cancer is boosting the demand for transfusion of blood and blood component, thereby augmenting apheresis market outlook in Europe.
 

Moreover, introduction of standards for maintaining the quality & safety of collection samples, and initiatives for collection, processing, storage, and distribution of blood & blood components are stimulating Europe apheresis equipment market trends.
 

Speaking of product type, Europe apheresis equipment industry is divided into apheresis machines and disposable apheresis kits. As per the report, disposable apheresis kit segment is projected to record a CAGR of 11% over the study period. Large volume procurement and low prices, as well as availability of top-quality kits for efficient pain management will propel the segmental growth.
 

Based on application spectrum, neurology segment accounted for over 50% revenue share of Europe apheresis equipment market in the year 2019, owing to rising incidences of neurological disorders like myasthenia gravis and multiple sclerosis which can be treated by healing plasma exchange. As per EAN (European Academy of Neurology), cases of neurological diseases in EU-28 were estimated to be 307 million.
 

Elaborating on procedure type, the industry is categorized into leukapheresis, LDL apheresis, erythrocytapheresis, plateletpheresis, plasmapheresis, photopheresis, and others. In 2019, the LDL apheresis segment of Europe apheresis equipment industry was worth USD 34 million. The procedure is performed outside the body, which involves removal of low-density lipoprotein cholesterol and sending remaining blood back into the body. LDL apheresis is recommended if the cholesterol levels are high despite cholesterol management and drug treatment.
 

Moving on to technology, Europe apheresis equipment market is categorized into centrifugation and membrane filtration. The report cites that membrane filtration segment is poised record 11% CAGR through 2026, as it faster and cheaper technique for plasma separation. In this technology, blood is pumped through membrane made of a thin layer of semi-permeable material, separating blood component from plasma.
 

Citing the regional landscape, France apheresis equipment industry size is likely to expand with a CAGR of 12.5% during the ensuing years. The growth is credited to rising healthcare expenditure along with increasing cases of blood related disorders. Notably, SCD (sickle cell disease) is a prevalent disorder in France, with 8,000 people affected by it. Therefore, surging need for transfusion in SCD patients will further fuel the industry expansion in the region.

Major players in Europe apheresis equipment market are Haemonetics Corporation, B. Braun Melsungen AG, Cerus Corporation, and Fresenius SE & Co. KGaA among others.